Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.486 SEK | -2.31% | -2.80% | -58.46% |
19/04 | AegirBio Unit Begins Arbitration Proceedings vs Salofa for Breach of Contract | MT |
09/04 | AegirBio Signs Conditional Agreement for SEK45 Million Loan With Atlas | MT |
Business Summary
Number of employees: 13
Sales per Business
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Covid-19 Saliva Test Viraspec
82.2
%
| 13 | 95.9 % | 1 | 82.2 % | -88.99% |
Custom Veritope Development Project
17.8
%
| - | - | 0 | 17.8 % | - |
Sales per region
SEK in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Sweden
82.2
%
| 9 | 69.7 % | 1 | 82.2 % | -84.86% |
United States
17.8
%
| - | - | 0 | 17.8 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marco Witteveen
CEO | Chief Executive Officer | - | 15/23/15 |
Director of Finance/CFO | - | 19/23/19 | |
Vasiliki Fragkou
COO | Chief Operating Officer | - | 01/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | 01/20/01 | |
Chairman | 67 | 01/19/01 | |
Sofia Bertling
BRD | Director/Board Member | 54 | 01/22/01 |
Fredrik Häglund
BRD | Director/Board Member | 49 | 01/20/01 |
William Vickery
BRD | Director/Board Member | 57 | 01/22/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 25,876,872 | 23,180,538 ( 89.58 %) | 0 | 89.58 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-58.46% | 1.41M | |
+8.78% | 218B | |
+7.63% | 183B | |
+13.32% | 134B | |
+24.70% | 106B | |
-1.14% | 61.12B | |
+4.81% | 50.89B | |
+1.19% | 40.3B | |
+2.92% | 35.53B | |
+27.61% | 32.05B |
- Stock Market
- Equities
- AEGIR Stock
- Company AegirBio AB